HMOX1 and neoplasm: Given that HO-1 is overexpressed in many cancers and implicated in tumor progression and resistance to chemotoxic agents and irradiation [4–8], the present finding supports the therapeutic potential of developing inhibitors of CPR-HO-1 interaction for cancer treatment.